Pathogenesis of Herpetic Stromal Keratitis in CCR5- and/or CXCR3-Deficient Mice

REFERENCES

• Kumaraguru U, Davis I, Rouse B T. Chemokines and ocular pathology caused by corneal infection with herpes simplex virus. J Neurovirol. 1999; 5: 42–47
   PubMed Web of Science ®Google Scholar
• Hendricks R L, Janowicz M, Tumpey T M. Critical role of corneal Langerhans cells in the CD4-but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas. J Immunol. 1992; 148: 2522–2529
   PubMed Web of Science ®Google Scholar
• Lewkowicz-Moss S J, Shimeld C, Lipworth K, et al. Quantitative studies on Langerhans cells in mouse corneal epithelium following infection with herpes simplex virus. Exp Eye Res. 1987; 45: 127–140
   PubMed Web of Science ®Google Scholar
• Miller J K, Laycock K A, Nash M M, Pepose J S. Corneal Langerhans cell dynamics after herpes simplex virus reactivation. Invest Ophthalmol Vis Sci. 1993; 34: 2282–2290
   PubMed Web of Science ®Google Scholar
• Thomas J, Rouse B T. Immunopathogenesis of herpetic ocular disease. Immunol Res. 1997; 16: 375–386
   PubMed Web of Science ®Google Scholar
• Thomas J, Gangappa S, Kanangat S, Rouse B T. On the essential involvement of neutrophils in the immunopathologic disease: Herpetic stromal keratitis. J Immunol. 1997; 158: 1383–1391
   PubMed Web of Science ®Google Scholar
• Deshpande S P, Zheng M, Lee S, Rouse B T. Mechanisms of pathogenesis in herpetic immunoinflammatory ocular lesions. Vet Microbiol. 2002; 86: 17–26
   PubMed Web of Science ®Google Scholar
• Doymaz M Z, Rouse B T. Herpetic stromal keratitis: An immunopathologic disease mediated by CD4+ T lymphocytes. Invest Ophthalmol Vis Sci. 1992; 33: 2165–2173
   PubMed Web of Science ®Google Scholar
• Biswas P S, Rouse B T. Early events in HSV keratitisSetting the stage for a blinding disease. Microbes Infect. 2005; 7: 799–810
   PubMed Web of Science ®Google Scholar
• Mosmann T R, Cherwinski H, Bond M W, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986; 136: 2348–2357
   PubMed Web of Science ®Google Scholar
• Del Prete G F, De Carli M, Mastromauro C, et al. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest. 1991; 88: 346–350
   PubMed Web of Science ®Google Scholar
• Salgame P, Abrams J S, Clayberger C, et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254: 279–282
   PubMed Web of Science ®Google Scholar
• Street N E, Schumacher J H, Fong T A, et al. Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J Immunol. 1990; 144: 1629–1639
   PubMed Web of Science ®Google Scholar
• Suzuki N, Nakajima A, Yoshino S, et al. Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol. 1999; 11: 553–559
   PubMed Web of Science ®Google Scholar
• Qin S, Rottman J B, Myers P, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest. 1998; 101: 746–754
   PubMed Web of Science ®Google Scholar
• Yamamoto J, Adachi Y, Onoue Y, et al. CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis. Allergy. 2000; 55: 1011–1018
   PubMed Web of Science ®Google Scholar
• Yoshie O, Imai T, Nomiyama H. Chemokines in immunity. Adv Immunol. 2001; 78: 57–110
   PubMed Web of Science ®Google Scholar
• Zlotnik A, Yoshie O. Chemokines: A new classification system and their role in immunity. Immunity. 2000; 12: 121–127
   PubMed Web of Science ®Google Scholar
• O'Garra A, McEvoy L M, Zlotnik A. T-cell subsets: Chemokine receptors guide the way. Curr Biol. 1998; 8: R646–649
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lenig D, Mackay C R, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. 1998; 187: 875–883
   PubMed Web of Science ®Google Scholar
• Bonecchi R, Bianchi G, Bordignon P P, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med. 1998; 187: 129–134
   PubMed Web of Science ®Google Scholar
• Imai T, Nagira M, Takagi S, et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol. 1999; 11: 81–88
   PubMed Web of Science ®Google Scholar
• Bleul C C, Wu L, Hoxie J A, , The H IV, et al. coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA. 1997; 94: 1925–1930
   PubMed Web of Science ®Google Scholar
• Schall T J, Bacon K, Toy K J, Goeddel D V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 1990; 347: 669–671
   PubMed Web of Science ®Google Scholar
• Taub D D, Conlon K, Lloyd A R, et al. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science. 1993; 260: 355–358
   PubMed Web of Science ®Google Scholar
• Flier J, Boorsma D M, van Beek P J, et al. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol. 2001; 194: 398–405
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Bauer D, Zheng M, et al. CD4+ T-cell type 1 and type 2 cytokines in the HSV-1 infected cornea. Graefes Arch Clin Exp Ophthalmol. 1999; 237: 399–406
   PubMed Web of Science ®Google Scholar
• Su Y H, Yan X T, Oakes J E, Lausch R N. Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection. J Virol. 1996; 70: 1277–1281
   PubMed Web of Science ®Google Scholar
• Tumpey T M, Cheng H, Cook D N, et al. Absence of macrophage inflammatory protein-1alpha prevents the development of blinding herpes stromal keratitis. J Virol. 1998; 72: 3705–3710
   PubMed Web of Science ®Google Scholar
• Cook W J, Kramer M F, Walker R M, et al. Persistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simplex virus 1 infection. Virol J 2004; 1: 5
   PubMed Web of Science ®Google Scholar
• Shirane J, Nakayama T, Nagakubo D, et al. Corneal epithelial cells and stromal keratocytes efficently produce CC chemokine-ligand 20 (CCL20) and attract cells expressing its receptor CCR6 in mouse herpetic stromal keratitis. Curr Eye Res. 2004; 28: 297–306
   PubMed Web of Science ®Google Scholar
• Spear P G, Roizman B. Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpes virion. J Virol. 1972; 9: 143–159
   PubMed Web of Science ®Google Scholar
• Newell C K, Martin S, Sendele D, et al. Herpes simplex virus-induced stromal keratitis: Role of T-lymphocyte subsets in immunopathology. J Virol. 1989; 63: 769–775
   PubMed Web of Science ®Google Scholar
• Miyazaki D, Inoue Y, Yao Y F, et al. T-cell-mediated immune responses in alloepithelial rejection after murine keratoepithelioplasty. Invest Ophthalmol Vis Sci. 1999; 40: 2590–2597
   PubMed Web of Science ®Google Scholar
• Shadidi K R, Thompson K M, Henriksen J E, et al. Association of antigen specificity and migratory capacity of memory T cells in rheumatoid arthritis. Scand J Immunol. 2002; 55: 274–283
   PubMed Web of Science ®Google Scholar
• Gao W, Faia K L, Csizmadia V, et al. Beneficial effects of targeting CCR5 in allograft recipients. Transplantation. 2001; 72: 1199–1205
   PubMed Web of Science ®Google Scholar
• Takeuchi A, Usui Y, Takeuchi M, et al. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response. Invest Ophthalmol Vis Sci. 2005; 46: 3753–3760
   PubMed Web of Science ®Google Scholar
• Wickham S, Lu B, Ash J, Carr D J. Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis. J Neuroimmunol. 2005; 162: 51–59
   PubMed Web of Science ®Google Scholar
• Carr D J, Ash J, Lane T E, Kuziel W A. Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1. J Gen Virol. 2006; 87: 489–499
   PubMed Web of Science ®Google Scholar
• Lundberg P, Cantin E. A potential role for CXCR3 chemokines in the response to ocular HSV infection. Curr Eye Res. 2003; 26: 137–150
   PubMed Web of Science ®Google Scholar
• Molesworth-Kenyon S, Mates A, Yin R, et al. CXCR3, IP-10, and Mig are required for CD4+ T cell recruitment during the DTH response to HSV-1 yet are independent of the mechanism for viral clearance. Virology. 2005; 333: 1–9
   PubMed Web of Science ®Google Scholar
• Sozzani S, Allavena P, Vecchi A, Mantovani A. The role of chemokines in the regulation of dendritic cell trafficking. J Leukoc Biol. 1999; 66: 1–9
   PubMed Web of Science ®Google Scholar
• von Andrian U H, Mackay C R. T-cell function and migration. Two sides of the same coin. N Engl J Med. 2000; 343: 1020–1034
   PubMed Web of Science ®Google Scholar
• Jones D, Benjamin R J, Shahsafaei A, Dorfman D M. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. Blood. 2000; 95: 627–632
   PubMed Web of Science ®Google Scholar
• Devalaraja M N, Richmond A. Multiple chemotactic factors: Fine control or redundancy?. Trends Pharmacol Sci. 1999; 20: 151–156
   PubMed Web of Science ®Google Scholar
• Tomoyuki I, Yoshitsugu I, Takako N, et al. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis. Invest Ophthalmol Vis Sci. 2000; 41: 4209–4215
   PubMed Web of Science ®Google Scholar